{"id": "F4.2-000016-P2", "question": "Which drugs target biomarkers of resistance to Platinum Compound in Ovarian Serous Carcinoma?", "gold_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t1:Therapy)\nWHERE (\n  toLower(t1.name) = toLower('Platinum Compound')\n  OR any(s IN coalesce(t1.synonyms, []) WHERE toLower(s) = toLower('Platinum Compound'))\n  OR toLower(t1.name) CONTAINS toLower('Platinum Compound')\n)\n  AND toLower(rel.effect) = 'resistance'\n  AND (\n    toLower(rel.disease_name) CONTAINS 'ovarian' AND\n    toLower(rel.disease_name) CONTAINS 'serous' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol\nWHERE gene_symbol IS NOT NULL\nMATCH (t2:Therapy)-[r:TARGETS]->(tg:Gene)\nWHERE (\n  toLower(tg.symbol) = toLower(gene_symbol)\n  OR any(s IN coalesce(tg.synonyms, []) WHERE toLower(s) = toLower(gene_symbol))\n)\n  AND toLower(t2.name) <> toLower('Platinum Compound')\nRETURN\n  gene_symbol,\n  t2.name AS therapy_name,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 100\n", "generated_cypher": "MATCH (gene:Gene), (therapy:Therapy), (biomarker:Biomarker)\nWHERE toLower(gene.symbol) IN [\n    'brca1', 'brca2', 'ercc1', 'ercc2', 'ercc3', 'ercc4', 'ercc5', 'ercc6', 'ercc7', 'ercc8', 'ercc9'\n]\nAND toLower(biomarker.name) CONTAINS 'resistance'\nAND toLower(therapy.name) CONTAINS 'platinum'\nAND (gene)-[:VARIANT_OF]->(gene)\nAND (therapy)-[:TARGETS]->(gene)\nAND (biomarker)-[:AFFECTS_RESPONSE_TO]->(therapy)\nRETURN DISTINCT therapy.name AS therapy_name, biomarker.name AS biomarker_name, gene.symbol AS gene_symbol\nORDER BY therapy_name\nLIMIT 10", "gold_rows": [{"gene_symbol": "AURKA", "therapy_name": "Alisertib", "targets_moa": "Serine/threonine-protein kinase Aurora-A inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["22016509"], "ref_urls": ["http://europepmc.org/abstract/MED/22016509"]}, {"gene_symbol": "AURKA", "therapy_name": "Tozasertib", "targets_moa": "Serine/threonine-protein kinase Aurora inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["14981513", "26345296"], "ref_urls": ["http://europepmc.org/abstract/MED/14981513", "http://europepmc.org/abstract/MED/26345296"]}], "generated_rows": [], "error": null}
{"id": "F4.1-000072-S1-P3", "question": "Show treatments hitting ALK that have biomarker evidence in Stromal Tumour Of Gastrointestinal Tract.", "gold_cypher": "MATCH (t:Therapy)-[:TARGETS]->(g:Gene)\nWHERE toLower(g.symbol) = toLower('ALK')\n   OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('ALK'))\nMATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'gastrointestinal' AND\n    toLower(rel.disease_name) CONTAINS 'stromal' AND\n    toLower(rel.disease_name) CONTAINS 'tumor'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(bg:Gene)\nRETURN\n  CASE WHEN b:Variant THEN b.name ELSE NULL END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE bg.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "generated_cypher": "MATCH (g:Gene {symbol: 'ALK'})-[:VARIANT_OF]->(v:Variant)\nWHERE EXISTS {\n  (v)-[:VARIANT_OF]->(g)\n}\nMATCH (t:Therapy)-[:TARGETS]->(g)\nWHERE toLower(t.name) CONTAINS 'ALK'\nWITH t\nMATCH (b:Biomarker)-[:AFFECTS_RESPONSE_TO]->(t)\nWHERE toLower(b.disease_name) CONTAINS 'stromal tumour of gastrointestinal tract'\nRETURN t.name AS therapy_name, b.name AS biomarker_name\nLIMIT 10", "gold_rows": [{"variant_name": "ETV6 ETV6::NTRK3 Fusion", "gene_symbol": "ETV6", "therapy_name": "Entrectinib", "effect": "sensitivity", "disease_name": "Gastrointestinal Stromal Tumor", "pmids": ["40900786"]}], "generated_rows": [], "error": null}
{"id": "F4.1-000096", "question": "Which therapies target ALK and also have biomarker evidence in Glioblastoma?", "gold_cypher": "MATCH (t:Therapy)-[:TARGETS]->(g:Gene)\nWHERE toLower(g.symbol) = toLower('ALK')\n   OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('ALK'))\nMATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'glioblastoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(bg:Gene)\nRETURN\n  CASE WHEN b:Variant THEN b.name ELSE NULL END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE bg.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "generated_cypher": "MATCH (g:Gene {symbol: 'ALK'})-[:VARIANT_OF]->(v:Variant)-[:VARIANT_OF]->(g)\nWHERE EXISTS {\n  (v)-[:VARIANT_OF]->(g)\n}\nMATCH (t:Therapy)-[:TARGETS]->(g)\nWHERE toLower(t.name) CONTAINS 'alk'\nWITH t\nMATCH (b:Biomarker)-[:AFFECTS_RESPONSE_TO]->(t)\nWHERE b.disease_name CONTAINS 'glioblastoma'\nRETURN t.name AS therapy_name, b.disease_name AS biomarker_disease, b.effect AS biomarker_effect\nORDER BY therapy_name\nLIMIT 10", "gold_rows": [{"variant_name": "ALK Expression", "gene_symbol": "ALK", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["26498130"]}, {"variant_name": "MET Amplification", "gene_symbol": "MET", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["22162573"]}, {"variant_name": "BCR BCR::NTRK2 Fusion", "gene_symbol": "BCR", "therapy_name": "Entrectinib", "effect": "sensitivity", "disease_name": "Brain Glioblastoma Multiforme", "pmids": ["35673607"]}, {"variant_name": "ETV6 ETV6::NTRK3 Fusion", "gene_symbol": "ETV6", "therapy_name": "Entrectinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["35395680"]}, {"variant_name": "GOPC GOPC::ROS1 e7::e35", "gene_symbol": "GOPC", "therapy_name": "Lorlatinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["30171048"]}], "generated_rows": [], "error": null}
{"id": "F2.2-000116-P3", "question": "How does SMARCB1 Deletion influence response to Tazemetostat for Epithelioid Sarcoma?", "gold_cypher": "MATCH (v:Variant {name: 'SMARCB1 Deletion'})-[:VARIANT_OF]->(g:Gene)\nMATCH (v)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Tazemetostat')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Tazemetostat'))\n  OR toLower(t.name) CONTAINS toLower('Tazemetostat')\n)\nAND (\n    toLower(rel.disease_name) CONTAINS 'epithelioid' AND\n    toLower(rel.disease_name) CONTAINS 'sarcoma'\n  )\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "generated_cypher": "MATCH (g:Gene {symbol: 'SMARCB1'})-[:VARIANT_OF]->(v:Variant)\nWHERE toLower(v.name) CONTAINS 'deletion'\nMATCH (t:Therapy {name: 'Tazemetostat'})-[:TARGETS]->(g)\nMATCH (d: Disease {name: 'Epithelioid Sarcoma'})\nRETURN \n  g.symbol AS gene,\n  v.name AS variant,\n  t.name AS therapy,\n  d.name AS disease,\n  coalesce(v.effect, []) AS effect,\n  coalesce(v.pmids, []) AS pmids,\n  coalesce(v.ref_sources, []) AS ref_sources,\n  coalesce(v.ref_ids, []) AS ref_ids,\n  coalesce(v.ref_urls, []) AS ref_urls,\n  coalesce((v.effect), []) AS variant_effect\nLIMIT 10", "gold_rows": [{"variant_name": "SMARCB1 Deletion", "gene_symbol": "SMARCB1", "therapy_name": "Tazemetostat", "effect": "sensitivity", "disease_name": "Epithelioid Sarcoma", "pmids": ["33035459"]}], "generated_rows": [], "error": null}
{"id": "F2.2-000017-S1-P2", "question": "Does TP53 Mutation predict response to Eprenetapopt in Malignant Tumor?", "gold_cypher": "MATCH (v:Variant {name: 'TP53 Mutation'})-[:VARIANT_OF]->(g:Gene)\nMATCH (v)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Eprenetapopt')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Eprenetapopt'))\n  OR toLower(t.name) CONTAINS toLower('Eprenetapopt')\n)\nAND (\n    toLower(rel.disease_name) CONTAINS 'cancer'\n  )\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "generated_cypher": "MATCH (g:Gene {symbol: 'TP53'})-[:VARIANT_OF]->(v:Variant)\nWHERE toLower(v.name) CONTAINS 'mutation'\nMATCH (t:Therapy {name: 'Eprenetapopt'})\nMATCH (d:Disease {name: 'Malignant Tumor'})\nRETURN \n  g.symbol AS gene_symbol,\n  v.name AS variant_name,\n  t.name AS therapy_name,\n  d.name AS disease_name,\n  coalesce(v.effect, []) AS effect,\n  coalesce(v.pmids, []) AS pmids,\n  coalesce(v.moa, []) AS moa,\n  coalesce(v.ref_sources, []) AS ref_sources,\n  coalesce(v.ref_ids, []) AS ref_ids,\n  coalesce(v.ref_urls, []) AS ref_urls,\n  coalesce(t.ref_sources, []) AS therapy_ref_sources,\n  coalesce(t.ref_ids, []) AS therapy_ref_ids,\n  coalesce(t.ref_urls, []) AS therapy_ref_urls\nLIMIT 10", "gold_rows": [{"variant_name": "TP53 Mutation", "gene_symbol": "TP53", "therapy_name": "Eprenetapopt", "effect": "sensitivity", "disease_name": "Cancer", "pmids": ["36084396"]}, {"variant_name": "TP53 Mutation", "gene_symbol": "TP53", "therapy_name": "Eprenetapopt", "effect": "sensitivity", "disease_name": "Ovarian Cancer", "pmids": ["26086967"]}], "generated_rows": [], "error": null}
{"id": "F1.3-000028", "question": "Which gene is BRAF Wildtype a variant of?", "gold_cypher": "MATCH (v:Variant {name: 'BRAF Wildtype'})-[:VARIANT_OF]->(g:Gene)\nRETURN g.symbol AS gene_symbol, v.name AS variant_name\nLIMIT 100\n", "generated_cypher": "MATCH (g:Gene {symbol: 'BRAF'})-[:VARIANT_OF]->(v:Variant)\nWHERE toLower(v.name) CONTAINS 'braf wildtype'\nRETURN g.symbol AS gene_symbol, v.name AS variant_name\nLIMIT 1", "gold_rows": [{"gene_symbol": "BRAF", "variant_name": "BRAF Wildtype"}], "generated_rows": [], "error": null}
{"id": "F1.3-000120-P1", "question": "PIK3CA H1047R OR PIK3CA H1047Y OR PIK3CA H1047L OR PIK3CA H1047D OR PIK3CA H1047I OR PIK3CA H1047N OR PIK3CA H1047P OR PIK3CA H1047Q OR PIK3CA H1047T belongs to which gene?", "gold_cypher": "MATCH (v:Variant {name: 'PIK3CA H1047R OR PIK3CA H1047Y OR PIK3CA H1047L OR PIK3CA H1047D OR PIK3CA H1047I OR PIK3CA H1047N OR PIK3CA H1047P OR PIK3CA H1047Q OR PIK3CA H1047T'})-[:VARIANT_OF]->(g:Gene)\nRETURN g.symbol AS gene_symbol, v.name AS variant_name\nLIMIT 100\n", "generated_cypher": "MATCH (v:Variant)-[:VARIANT_OF]->(g:Gene)\nWHERE toLower(g.symbol) = 'pi3kca'\n  AND v.name CONTAINS 'h1047r'\n  OR v.name CONTAINS 'h1047y'\n  OR v.name CONTAINS 'h1047l'\n  OR v.name CONTAINS 'h1047d'\n  OR v.name CONTAINS 'h1047i'\n  OR v.name CONTAINS 'h1047n'\n  OR v.name CONTAINS 'h1047p'\n  OR v.name CONTAINS 'h1047q'\n  OR v.name CONTAINS 'h1047t'\nRETURN g.symbol AS gene_symbol\nLIMIT 10", "gold_rows": [{"gene_symbol": "PIK3CA", "variant_name": "PIK3CA H1047R OR PIK3CA H1047Y OR PIK3CA H1047L OR PIK3CA H1047D OR PIK3CA H1047I OR PIK3CA H1047N OR PIK3CA H1047P OR PIK3CA H1047Q OR PIK3CA H1047T"}], "generated_rows": [], "error": null}
{"id": "F2.2-000180-P3", "question": "What genes are resistance biomarkers for Erlotinib in Lung Cancer?", "gold_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Erlotinib')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Erlotinib'))\n  OR toLower(t.name) CONTAINS toLower('Erlotinib')\n)\nAND toLower(rel.effect) = 'resistance'\nAND (\n    toLower(rel.disease_name) CONTAINS 'lung'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  'resistance' AS effect,\n  disease_name,\n  pmids\nLIMIT 100\n", "generated_cypher": "MATCH (g:Gene), (v:Variant)-[:VARIANT_OF]->(g), (t:Therapy {name: 'Erlotinib'})\nWHERE toLower(g.symbol) IN [\n  'egfr', 'ephrin', 'egfr', 'egfr', 'egfr'\n]\nWITH g\nWHERE exists(\n  (v)-[:VARIANT_OF]->(g)\n)\nAND (g.symbol IN [\n  'egfr', 'egfr', 'egfr', 'egfr', 'egfr'\n])\nAND (g.symbol IN [\n  'egfr', 'egfr', 'egfr', 'egfr', 'egfr'\n])\nAND (g.symbol IN [\n  'egfr', 'egfr', 'egfr', 'egfr', 'egfr'\n])\nRETURN g.symbol AS gene_symbol\nLIMIT 10;", "gold_rows": [{"variant_name": null, "gene_symbol": "BRAF", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["22773810"]}, {"variant_name": null, "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Adenocarcinoma", "pmids": ["24353160", "23371856", "16407879", "26096453", "22895145", "26773740", "27032107", "23470965", "17085664", "19010870"]}, {"variant_name": null, "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["21132006", "17877814", "17085664", "24353160", "19147750", "19786660", "21841502", "25668228", "27304188", "15737014"]}, {"variant_name": null, "gene_symbol": "EML4", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Acinar Adenocarcinoma", "pmids": ["23181703"]}, {"variant_name": null, "gene_symbol": "ERBB2", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Adenocarcinoma", "pmids": ["23470965"]}, {"variant_name": null, "gene_symbol": "ERBB2", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["16818618"]}, {"variant_name": null, "gene_symbol": "FGFR4", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Adenocarcinoma", "pmids": ["31027687"]}, {"variant_name": null, "gene_symbol": "GNAS", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24758907"]}, {"variant_name": null, "gene_symbol": "KRAS", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["15696205", "22982650", "24351425", "21969500", "22025157"]}, {"variant_name": null, "gene_symbol": "KRAS", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Adenocarcinoma", "pmids": ["19794967"]}, {"variant_name": null, "gene_symbol": "KRAS", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Cancer", "pmids": ["16043828", "2199829"]}, {"variant_name": null, "gene_symbol": "MET", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Adenocarcinoma", "pmids": ["23470965"]}, {"variant_name": null, "gene_symbol": "NRAS", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["22773810"]}, {"variant_name": null, "gene_symbol": "NRG1", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26418897"]}, {"variant_name": null, "gene_symbol": "PIK3CA", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Adenocarcinoma", "pmids": ["27304188"]}, {"variant_name": null, "gene_symbol": "PIK3CA", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["21258250"]}], "generated_rows": [], "error": null}
{"id": "F2.2-000165", "question": "Which genes predict resistance to Docetaxel in Stomach Cancer?", "gold_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Docetaxel')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Docetaxel'))\n  OR toLower(t.name) CONTAINS toLower('Docetaxel')\n)\nAND toLower(rel.effect) = 'resistance'\nAND (\n    toLower(rel.disease_name) CONTAINS 'stomach'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  'resistance' AS effect,\n  disease_name,\n  pmids\nLIMIT 100\n", "generated_cypher": "MATCH (g:Gene), (v:Variant)-[:VARIANT_OF]->(g), (d:Disease {name: 'Stomach Cancer'})\nWHERE toLower(d.name) CONTAINS 'stomach cancer'\nWITH g, v\nWHERE v.effect CONTAINS 'resistance' OR v.effect CONTAINS 'resistant'\nRETURN g.symbol AS gene_symbol, v.name AS variant_name\nORDER BY gene_symbol\nLIMIT 10", "gold_rows": [{"variant_name": null, "gene_symbol": "PTEN", "therapy_name": "Docetaxel", "effect": "resistance", "disease_name": "Stomach Cancer", "pmids": ["24088382"]}], "generated_rows": [], "error": null}
{"id": "F2.2-000166-P2", "question": "List genes associated with resistance to Imatinib Mesylate in Acute Myeloid Leukemia.", "gold_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Imatinib Mesylate')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Imatinib Mesylate'))\n  OR toLower(t.name) CONTAINS toLower('Imatinib Mesylate')\n)\nAND toLower(rel.effect) = 'resistance'\nAND (\n    toLower(rel.disease_name) CONTAINS 'acute' AND\n    toLower(rel.disease_name) CONTAINS 'myeloid' AND\n    toLower(rel.disease_name) CONTAINS 'leukemia'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  'resistance' AS effect,\n  disease_name,\n  pmids\nLIMIT 100\n", "generated_cypher": "MATCH (g:Gene), (v:Variant)-[:VARIANT_OF]->(g), (d:Disease {name: 'Acute Myeloid Leukemia'})\nWHERE toLower(v.name) CONTAINS 'resistance' AND toLower(d.name) CONTAINS 'acute myeloid leukemia'\nWITH g\nRETURN g.symbol AS gene_symbol\nLIMIT 10", "gold_rows": [{"variant_name": null, "gene_symbol": "KIT", "therapy_name": "Imatinib Mesylate", "effect": "resistance", "disease_name": "Acute Myeloid Leukemia", "pmids": ["15650049"]}], "generated_rows": [], "error": null}
{"id": "F2.4-000056-P2", "question": "Report the consequence for VHL c.340+770T>C.", "gold_cypher": "MATCH (v:Variant {name: 'VHL c.340+770T>C'})\nRETURN\n  v.name AS variant_name,\n  v.consequence AS variant_consequence\nLIMIT 100\n", "generated_cypher": "MATCH (g:Gene {symbol: 'VHL'})-[:VARIANT_OF]->(v:Variant {name: 'c.340+770T>C'})\nRETURN v.effect, v.moa, v.pmids, v.ref_sources, v.ref_ids, v.ref_urls\nLIMIT 10", "gold_rows": [{"variant_name": "VHL c.340+770T>C", "variant_consequence": null}], "generated_rows": [], "error": null}
{"id": "F2.4-000035", "question": "What is the consequence of the EGFR R705K variant?", "gold_cypher": "MATCH (v:Variant {name: 'EGFR R705K'})\nRETURN\n  v.name AS variant_name,\n  v.consequence AS variant_consequence\nLIMIT 100\n", "generated_cypher": "MATCH (g:Gene {symbol: 'EGFR'})-[:VARIANT_OF]->(v:Variant)\nWHERE toLower(v.name) CONTAINS 'r705k'\nRETURN v.effect, v.pmids, v.ref_sources, v.ref_ids, v.ref_urls\nLIMIT 10", "gold_rows": [{"variant_name": "EGFR R705K", "variant_consequence": null}], "generated_rows": [], "error": null}
{"id": "F6.2-000094", "question": "What therapies target TOP1 but NOT PSMA1, and have biomarker evidence in Ureter Small Cell Carcinoma?", "gold_cypher": "MATCH (t:Therapy)-[:TARGETS]->(gi:Gene)\nWHERE toLower(gi.symbol) = toLower('TOP1')\n   OR any(s IN coalesce(gi.synonyms, []) WHERE toLower(s) = toLower('TOP1'))\nOPTIONAL MATCH (t)-[:TARGETS]->(gx:Gene)\nWHERE toLower(gx.symbol) = toLower('PSMA1')\n   OR any(s IN coalesce(gx.synonyms, []) WHERE toLower(s) = toLower('PSMA1'))\nWITH t, gi, gx\nWHERE gx IS NULL\nMATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'ureter' AND\n    toLower(rel.disease_name) CONTAINS 'small' AND\n    toLower(rel.disease_name) CONTAINS 'cell' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nRETURN\n  CASE WHEN b:Variant THEN b.name ELSE NULL END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "generated_cypher": "MATCH (g:Gene), (v:Variant)-[:VARIANT_OF]->(g), (t:Therapy)-[:TARGETS]->(g)\nWHERE g.symbol = 'TOP1'\n  AND NOT EXISTS {\n    (g:Gene)-[:VARIANT_OF]->(v)\n    WHERE v.name CONTAINS 'PSMA1'\n  }\n  AND EXISTS {\n    (b:Biomarker)-[:AFFECTS_RESPONSE_TO]->(t)\n    WHERE b.name CONTAINS 'Ureter Small Cell Carcinoma'\n  }\nRETURN t.name AS therapy_name\nLIMIT 10", "gold_rows": [{"variant_name": "RAD50 L1237F", "gene_symbol": "RAD50", "therapy_name": "Irinotecan", "effect": "sensitivity", "disease_name": "Ureter Small Cell Carcinoma", "pmids": ["24934408"]}], "generated_rows": [], "error": null}
{"id": "F6.2-000167-P3", "question": "Show treatments for TOP1 excluding POLD3 that have biomarker evidence in Ureter Small Cell Carcinoma.", "gold_cypher": "MATCH (t:Therapy)-[:TARGETS]->(gi:Gene)\nWHERE toLower(gi.symbol) = toLower('TOP1')\n   OR any(s IN coalesce(gi.synonyms, []) WHERE toLower(s) = toLower('TOP1'))\nOPTIONAL MATCH (t)-[:TARGETS]->(gx:Gene)\nWHERE toLower(gx.symbol) = toLower('POLD3')\n   OR any(s IN coalesce(gx.synonyms, []) WHERE toLower(s) = toLower('POLD3'))\nWITH t, gi, gx\nWHERE gx IS NULL\nMATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'ureter' AND\n    toLower(rel.disease_name) CONTAINS 'small' AND\n    toLower(rel.disease_name) CONTAINS 'cell' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nRETURN\n  CASE WHEN b:Variant THEN b.name ELSE NULL END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "generated_cypher": "MATCH (g:Gene {symbol: 'TOP1'})-[:VARIANT_OF]->(v:Variant)-[:TARGETS]->(t:Therapy)\nWHERE toLower(t.name) <> 'pold3'\nWITH t\nMATCH (b:Biomarker)-[:AFFECTS_RESPONSE_TO]->(t)\nWHERE toLower(b.name) CONTAINS 'ureter small cell carcinoma'\nRETURN t.name AS therapy_name, b.name AS biomarker_name\nLIMIT 10", "gold_rows": [{"variant_name": "RAD50 L1237F", "gene_symbol": "RAD50", "therapy_name": "Irinotecan", "effect": "sensitivity", "disease_name": "Ureter Small Cell Carcinoma", "pmids": ["24934408"]}], "generated_rows": [], "error": null}
{"id": "F5.2-000096-P2", "question": "Show drugs with variant-based evidence in T-cell Acute Lymphoblastic Leukemia.", "gold_cypher": "MATCH (v:Variant)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 't-cell' AND\n    toLower(rel.disease_name) CONTAINS 'acute' AND\n    toLower(rel.disease_name) CONTAINS 'lymphoblastic' AND\n    toLower(rel.disease_name) CONTAINS 'leukemia'\n  )\nOPTIONAL MATCH (v)-[:VARIANT_OF]->(g:Gene)\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "generated_cypher": "MATCH (g:Gene)-[:VARIANT_OF]->(v:Variant)-[:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE toLower(g.symbol) CONTAINS 'tcell acute lymphoblastic leukemia' OR\n      toLower(v.name) CONTAINS 'tcell acute lymphoblastic leukemia'\nRETURN DISTINCT t.name AS therapy_name, \n       g.symbol AS gene_symbol, \n       v.name AS variant_name,\n       coalesce(t.effect, []) AS effect,\n       coalesce(t.pmids, []) AS pmids,\n       coalesce(t.moa, []) AS moa,\n       coalesce(t.ref_sources, []) AS ref_sources,\n       coalesce(t.ref_ids, []) AS ref_ids,\n       coalesce(t.ref_urls, []) AS ref_urls\nLIMIT 10", "gold_rows": [{"variant_name": "NT5C2 D407A", "gene_symbol": "NT5C2", "therapy_name": "Arabinosylguanine", "effect": "resistance", "disease_name": "T-cell Acute Lymphoblastic Leukemia", "pmids": ["23377281"]}, {"variant_name": "NT5C2 K359Q", "gene_symbol": "NT5C2", "therapy_name": "Arabinosylguanine", "effect": "resistance", "disease_name": "T-cell Acute Lymphoblastic Leukemia", "pmids": ["23377281"]}, {"variant_name": "NT5C2 R367Q", "gene_symbol": "NT5C2", "therapy_name": "Arabinosylguanine", "effect": "resistance", "disease_name": "T-cell Acute Lymphoblastic Leukemia", "pmids": ["23377281"]}, {"variant_name": "NT5C2 D407A", "gene_symbol": "NT5C2", "therapy_name": "Mercaptopurine", "effect": "resistance", "disease_name": "T-cell Acute Lymphoblastic Leukemia", "pmids": ["23377281"]}, {"variant_name": "NT5C2 K359Q", "gene_symbol": "NT5C2", "therapy_name": "Mercaptopurine", "effect": "resistance", "disease_name": "T-cell Acute Lymphoblastic Leukemia", "pmids": ["23377281"]}, {"variant_name": "NT5C2 R367Q", "gene_symbol": "NT5C2", "therapy_name": "Mercaptopurine", "effect": "resistance", "disease_name": "T-cell Acute Lymphoblastic Leukemia", "pmids": ["23377281"]}, {"variant_name": "NT5C2 D407A", "gene_symbol": "NT5C2", "therapy_name": "Nelarabine", "effect": "resistance", "disease_name": "T-cell Acute Lymphoblastic Leukemia", "pmids": ["23377281"]}, {"variant_name": "NT5C2 K359Q", "gene_symbol": "NT5C2", "therapy_name": "Nelarabine", "effect": "resistance", "disease_name": "T-cell Acute Lymphoblastic Leukemia", "pmids": ["23377281"]}, {"variant_name": "NT5C2 R367Q", "gene_symbol": "NT5C2", "therapy_name": "Nelarabine", "effect": "resistance", "disease_name": "T-cell Acute Lymphoblastic Leukemia", "pmids": ["23377281"]}, {"variant_name": "NOTCH1 F1592C", "gene_symbol": "NOTCH1", "therapy_name": "Prednisone", "effect": "sensitivity", "disease_name": "T-cell Acute Lymphoblastic Leukemia", "pmids": ["16614245"]}, {"variant_name": "NOTCH1 F1592S", "gene_symbol": "NOTCH1", "therapy_name": "Prednisone", "effect": "sensitivity", "disease_name": "T-cell Acute Lymphoblastic Leukemia", "pmids": ["16614245"]}, {"variant_name": "NOTCH1 L1574P", "gene_symbol": "NOTCH1", "therapy_name": "Prednisone", "effect": "sensitivity", "disease_name": "T-cell Acute Lymphoblastic Leukemia", "pmids": ["16614245"]}, {"variant_name": "NOTCH1 L1574Q", "gene_symbol": "NOTCH1", "therapy_name": "Prednisone", "effect": "sensitivity", "disease_name": "T-cell Acute Lymphoblastic Leukemia", "pmids": ["16614245"]}, {"variant_name": "NOTCH1 L1585R", "gene_symbol": "NOTCH1", "therapy_name": "Prednisone", "effect": "sensitivity", "disease_name": "T-cell Acute Lymphoblastic Leukemia", "pmids": ["16614245"]}, {"variant_name": "NOTCH1 L1600P", "gene_symbol": "NOTCH1", "therapy_name": "Prednisone", "effect": "sensitivity", "disease_name": "T-cell Acute Lymphoblastic Leukemia", "pmids": ["16614245"]}, {"variant_name": "NOTCH1 L1600Q", "gene_symbol": "NOTCH1", "therapy_name": "Prednisone", "effect": "sensitivity", "disease_name": "T-cell Acute Lymphoblastic Leukemia", "pmids": ["16614245"]}, {"variant_name": "NOTCH1 Mutation", "gene_symbol": "NOTCH1", "therapy_name": "Prednisone", "effect": "sensitivity", "disease_name": "T-cell Acute Lymphoblastic Leukemia", "pmids": ["16614245"]}, {"variant_name": "NOTCH1 V1577A", "gene_symbol": "NOTCH1", "therapy_name": "Prednisone", "effect": "sensitivity", "disease_name": "T-cell Acute Lymphoblastic Leukemia", "pmids": ["16614245"]}, {"variant_name": "NOTCH1 V1577E", "gene_symbol": "NOTCH1", "therapy_name": "Prednisone", "effect": "sensitivity", "disease_name": "T-cell Acute Lymphoblastic Leukemia", "pmids": ["16614245"]}, {"variant_name": "MTOR C1483Y", "gene_symbol": "MTOR", "therapy_name": "Sirolimus", "effect": "sensitivity", "disease_name": "T-cell Acute Lymphoblastic Leukemia", "pmids": ["24631838"]}, {"variant_name": "NT5C2 D407A", "gene_symbol": "NT5C2", "therapy_name": "Thioguanine", "effect": "resistance", "disease_name": "T-cell Acute Lymphoblastic Leukemia", "pmids": ["23377281"]}, {"variant_name": "NT5C2 K359Q", "gene_symbol": "NT5C2", "therapy_name": "Thioguanine", "effect": "resistance", "disease_name": "T-cell Acute Lymphoblastic Leukemia", "pmids": ["23377281"]}, {"variant_name": "NT5C2 R367Q", "gene_symbol": "NT5C2", "therapy_name": "Thioguanine", "effect": "resistance", "disease_name": "T-cell Acute Lymphoblastic Leukemia", "pmids": ["23377281"]}, {"variant_name": "JAK3 M511I", "gene_symbol": "JAK3", "therapy_name": "Tofacitinib", "effect": "sensitivity", "disease_name": "T-cell Acute Lymphoblastic Leukemia", "pmids": ["25193870"]}], "generated_rows": [], "error": null}
{"id": "F5.2-000015-S1-P1", "question": "Which therapies have variant biomarkers in Squamous Cell Carcinomas Of Head And Neck?", "gold_cypher": "MATCH (v:Variant)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'head' AND\n    toLower(rel.disease_name) CONTAINS 'and' AND\n    toLower(rel.disease_name) CONTAINS 'neck' AND\n    toLower(rel.disease_name) CONTAINS 'squamous' AND\n    toLower(rel.disease_name) CONTAINS 'cell' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nOPTIONAL MATCH (v)-[:VARIANT_OF]->(g:Gene)\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "generated_cypher": "MATCH (gene:Gene), (variant:Variant)-[:VARIANT_OF]->(gene), (therapy:Therapy)-[:TARGETS]->(gene)\nWHERE toLower(gene.symbol) CONTAINS 'squamous cell carcinoma of head and neck'\nRETURN therapy.name AS therapy_name\nLIMIT 100", "gold_rows": [{"variant_name": "CDKN2A p16 Expression", "gene_symbol": "CDKN2A", "therapy_name": "Afatinib", "effect": "resistance", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["25892145"]}, {"variant_name": "EGFR Amplification", "gene_symbol": "EGFR", "therapy_name": "Afatinib", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["27207775"]}, {"variant_name": "ERBB2 S1050L", "gene_symbol": "ERBB2", "therapy_name": "Afatinib", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["27207775"]}, {"variant_name": "ERBB4 G1109C", "gene_symbol": "ERBB4", "therapy_name": "Afatinib", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["27207775"]}, {"variant_name": "AURKB Overexpression", "gene_symbol": "AURKB", "therapy_name": "Alisertib", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["36169922"]}, {"variant_name": "HRAS G12V", "gene_symbol": "HRAS", "therapy_name": "Alpelisib", "effect": "resistance", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["30115483"]}, {"variant_name": "PIK3CA E542K", "gene_symbol": "PIK3CA", "therapy_name": "Apitolisib", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["26787751"]}, {"variant_name": "PIK3CA Amplification", "gene_symbol": "PIK3CA", "therapy_name": "Aspirin", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["30683736"]}, {"variant_name": "PIK3CA Mutation", "gene_symbol": "PIK3CA", "therapy_name": "Aspirin", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["30683736"]}, {"variant_name": "AURKB Overexpression", "gene_symbol": "AURKB", "therapy_name": "Barasertib", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["36169922"]}, {"variant_name": "PIK3CA Mutation", "gene_symbol": "PIK3CA", "therapy_name": "Celecoxib", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["30683736"]}, {"variant_name": "AREG Expression", "gene_symbol": "AREG", "therapy_name": "Cetuximab", "effect": "resistance", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["21653686"]}, {"variant_name": "CDKN2A p16 Expression", "gene_symbol": "CDKN2A", "therapy_name": "Cetuximab", "effect": "resistance", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["24577089"]}, {"variant_name": "EGF EXPRESSION", "gene_symbol": "EGF", "therapy_name": "Cetuximab", "effect": "resistance", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["25677871"]}, {"variant_name": "EGFR Amplification", "gene_symbol": "EGFR", "therapy_name": "Cetuximab", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["21048039", "27207775"]}, {"variant_name": "EGFR Overexpression", "gene_symbol": "EGFR", "therapy_name": "Cetuximab", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["21653686"]}, {"variant_name": "EGFR P546S", "gene_symbol": "EGFR", "therapy_name": "Cetuximab", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["23578570"]}, {"variant_name": "EGFR VIII", "gene_symbol": "EGFR", "therapy_name": "Cetuximab", "effect": "resistance", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["21653686"]}, {"variant_name": "ERBB2 S1050L", "gene_symbol": "ERBB2", "therapy_name": "Cetuximab", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["27207775"]}, {"variant_name": "ERBB3 R1202W", "gene_symbol": "ERBB3", "therapy_name": "Cetuximab", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["27207775"]}, {"variant_name": "NRAS G13V", "gene_symbol": "NRAS", "therapy_name": "Cetuximab", "effect": "resistance", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["28259104"]}, {"variant_name": "SMAD4 Underexpression", "gene_symbol": "SMAD4", "therapy_name": "Cetuximab", "effect": "resistance", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["26046389"]}, {"variant_name": "CDKN1B EXPRESSION", "gene_symbol": "CDKN1B", "therapy_name": "Cisplatin", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["24239278"]}, {"variant_name": "KRAS RS61764370", "gene_symbol": "KRAS", "therapy_name": "Cisplatin", "effect": "resistance", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["25081901"]}, {"variant_name": "AURKB Overexpression", "gene_symbol": "AURKB", "therapy_name": "Copanlisib", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["36169922"]}, {"variant_name": "AREG Expression", "gene_symbol": "AREG", "therapy_name": "Docetaxel", "effect": "resistance", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["21653686"]}, {"variant_name": "EGFR Overexpression", "gene_symbol": "EGFR", "therapy_name": "Docetaxel", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["21653686"]}, {"variant_name": "EGFR VIII", "gene_symbol": "EGFR", "therapy_name": "Docetaxel", "effect": "resistance", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["21653686"]}, {"variant_name": "CDKN2A p16 Expression", "gene_symbol": "CDKN2A", "therapy_name": "Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor", "effect": "resistance", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["24577117"]}, {"variant_name": "EGFR Amplification", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["27207775"]}, {"variant_name": "ERBB2 S1050L", "gene_symbol": "ERBB2", "therapy_name": "Erlotinib", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["27207775"]}, {"variant_name": "ERBB3 R1202W", "gene_symbol": "ERBB3", "therapy_name": "Erlotinib", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["27207775"]}, {"variant_name": "ERBB4 G1109C", "gene_symbol": "ERBB4", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["27207775"]}, {"variant_name": "MAPK1 E278E", "gene_symbol": "MAPK1", "therapy_name": "Erlotinib", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["26181029"]}, {"variant_name": "MAPK1 E322K", "gene_symbol": "MAPK1", "therapy_name": "Erlotinib", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["26181029", "27004400"]}, {"variant_name": "CDKN1B EXPRESSION", "gene_symbol": "CDKN1B", "therapy_name": "Fluorouracil", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["24239278"]}, {"variant_name": "DPYD EXON 11-19 DELETION", "gene_symbol": "DPYD", "therapy_name": "Fluorouracil", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["31871216"]}, {"variant_name": "EGFR Amplification", "gene_symbol": "EGFR", "therapy_name": "Fluorouracil", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["21048039"]}, {"variant_name": "PIK3CA Amplification", "gene_symbol": "PIK3CA", "therapy_name": "Ibuprofen", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["30683736"]}, {"variant_name": "FGFR1 Expression", "gene_symbol": "FGFR1", "therapy_name": "Infigratinib", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["26015511"]}, {"variant_name": "PTPRT Promoter Hypermethylation", "gene_symbol": "PTPRT", "therapy_name": "JSI-124", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["25982282"]}, {"variant_name": "ERBB2 Overexpression", "gene_symbol": "ERBB2", "therapy_name": "Lapatinib", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["28061634"]}, {"variant_name": "NRG1 Expression", "gene_symbol": "NRG1", "therapy_name": "Lapatinib", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["21840482"]}, {"variant_name": "DPYD EXON 11-19 DELETION", "gene_symbol": "DPYD", "therapy_name": "Leucovorin", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["31871216"]}, {"variant_name": "CDKN2A p16 Expression", "gene_symbol": "CDKN2A", "therapy_name": "Panitumumab", "effect": "resistance", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["23746666"]}, {"variant_name": "CDKN2A p16 Expression", "gene_symbol": "CDKN2A", "therapy_name": "Panitumumab", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["23746666"]}, {"variant_name": "FGFR2 P253R", "gene_symbol": "FGFR2", "therapy_name": "Pazopanib", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["23786770"]}, {"variant_name": "EGFR Amplification", "gene_symbol": "EGFR", "therapy_name": "Platinum Compound", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["21048039"]}, {"variant_name": "NOTCH1 Loss-of-function", "gene_symbol": "NOTCH1", "therapy_name": "Porcupine Inhibitor WNT974", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["24277854"]}, {"variant_name": "CD274 Expression", "gene_symbol": "CD274", "therapy_name": "Radiation Therapy", "effect": "resistance", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["28476872"]}, {"variant_name": "PIK3CA Mutation", "gene_symbol": "PIK3CA", "therapy_name": "Radiation Therapy", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["26589432"]}, {"variant_name": "PTPRT Promoter Hypermethylation", "gene_symbol": "PTPRT", "therapy_name": "Stattic", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["25982282"]}, {"variant_name": "PIK3CA Amplification", "gene_symbol": "PIK3CA", "therapy_name": "Sulindac", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["30683736"]}, {"variant_name": "PIK3CA Mutation", "gene_symbol": "PIK3CA", "therapy_name": "Sulindac", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["30683736"]}, {"variant_name": "PIK3CA Amplification", "gene_symbol": "PIK3CA", "therapy_name": "Taselisib", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["26589432"]}, {"variant_name": "PIK3CA H1047R", "gene_symbol": "PIK3CA", "therapy_name": "Taselisib", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["26589432"]}, {"variant_name": "PIK3CA Mutation", "gene_symbol": "PIK3CA", "therapy_name": "Taselisib", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["26589432"]}, {"variant_name": "PTEN Mutation", "gene_symbol": "PTEN", "therapy_name": "Taselisib", "effect": "resistance", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["26589432"]}, {"variant_name": "HRAS Mutation", "gene_symbol": "HRAS", "therapy_name": "Tipifarnib", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["33750196"]}, {"variant_name": "ALDH1A2 Underexpression", "gene_symbol": "ALDH1A2", "therapy_name": "Tretinoin", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["26634247"]}], "generated_rows": [], "error": null}
{"id": "F2.2-000200-P3", "question": "How does KRAS Mutation influence response to Refametinib for Colorectal Cancer?", "gold_cypher": "MATCH (v:Variant {name: 'KRAS Mutation'})-[:VARIANT_OF]->(g:Gene)\nMATCH (v)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Refametinib')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Refametinib'))\n  OR toLower(t.name) CONTAINS toLower('Refametinib')\n)\nAND (\n    toLower(rel.disease_name) CONTAINS 'colorectal'\n  )\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "generated_cypher": "MATCH (g:Gene {symbol: 'KRAS'})-[:VARIANT_OF]->(v:Variant)\nWHERE v.name CONTAINS 'mutation'\nOPTIONAL MATCH (t:Therapy {name: 'Refametinib'})-[:TARGETS]->(g)\nOPTIONAL MATCH (d:Disease {name: 'Colorectal Cancer'})\nRETURN \n  coalesce(v.name, []) as variant,\n  coalesce(t.name, []) as therapy,\n  coalesce(d.name, []) as disease,\n  coalesce(g.effect, []) as gene_effect,\n  coalesce(g.moa, []) as mechanism_of_action,\n  coalesce(g.ref_sources, []) as references\nLIMIT 10", "gold_rows": [{"variant_name": "KRAS Mutation", "gene_symbol": "KRAS", "therapy_name": "Refametinib", "effect": "sensitivity", "disease_name": "Colorectal Cancer", "pmids": ["23434733"]}], "generated_rows": [], "error": null}
{"id": "F2.2-000159", "question": "How does the variant PIK3CA Mutation affect response to Ribociclib in Breast Cancer?", "gold_cypher": "MATCH (v:Variant {name: 'PIK3CA Mutation'})-[:VARIANT_OF]->(g:Gene)\nMATCH (v)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Ribociclib')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Ribociclib'))\n  OR toLower(t.name) CONTAINS toLower('Ribociclib')\n)\nAND (\n    toLower(rel.disease_name) CONTAINS 'breast'\n  )\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "generated_cypher": "MATCH (g:Gene {symbol: 'PIK3CA'})-[:VARIANT_OF]->(v:Variant {name: 'PIK3CA Mutation'})-[:AFFECTS_RESPONSE_TO]->(t:Therapy {name: 'Ribociclib'})\nWHERE toLower(g.symbol) = 'pi3ca' OR toLower(g.symbol) CONTAINS 'pi3ca'\n  AND toLower(t.name) = 'ribociclib'\n  AND (v.name CONTAINS 'mutation' OR v.name CONTAINS 'pi3ca')\nRETURN \n  g.symbol AS gene_symbol,\n  v.name AS variant_name,\n  t.name AS therapy_name,\n  coalesce(v.effect, []) AS effect,\n  coalesce(v.pmids, []) AS pmids,\n  coalesce(v.ref_sources, []) AS ref_sources,\n  coalesce(v.ref_ids, []) AS ref_ids,\n  coalesce(v.ref_urls, []) AS ref_urls,\n  coalesce(t.moa, []) AS moa,\n  coalesce(t.ref_sources, []) AS therapy_ref_sources,\n  coalesce(t.ref_ids, []) AS therapy_ref_ids,\n  coalesce(t.ref_urls, []) AS therapy_ref_urls\nLIMIT 10", "gold_rows": [{"variant_name": "PIK3CA Mutation", "gene_symbol": "PIK3CA", "therapy_name": "Ribociclib", "effect": "sensitivity", "disease_name": "Breast Cancer", "pmids": ["25002028"]}], "generated_rows": [], "error": null}
{"id": "F2.2-000159-P2", "question": "Does PIK3CA Mutation predict response to Ribociclib in Breast Cancer?", "gold_cypher": "MATCH (v:Variant {name: 'PIK3CA Mutation'})-[:VARIANT_OF]->(g:Gene)\nMATCH (v)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Ribociclib')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Ribociclib'))\n  OR toLower(t.name) CONTAINS toLower('Ribociclib')\n)\nAND (\n    toLower(rel.disease_name) CONTAINS 'breast'\n  )\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "generated_cypher": "MATCH (g:Gene {symbol: 'PIK3CA'})-[:VARIANT_OF]->(v:Variant)\nWHERE toLower(v.name) CONTAINS 'mutation'\nMATCH (t:Therapy {name: 'Ribociclib'})-[:TARGETS]->(g)\nRETURN g.symbol AS gene_symbol, v.name AS variant, t.name AS therapy, 'Yes' AS predicts_response\nLIMIT 10", "gold_rows": [{"variant_name": "PIK3CA Mutation", "gene_symbol": "PIK3CA", "therapy_name": "Ribociclib", "effect": "sensitivity", "disease_name": "Breast Cancer", "pmids": ["25002028"]}], "generated_rows": [], "error": null}
{"id": "F1.1-000036-P1", "question": "Which therapies target TUBA3C?", "gold_cypher": "MATCH (t:Therapy)-[r:TARGETS]->(g:Gene)\nWHERE toLower(g.symbol) = toLower('TUBA3C')\n   OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('TUBA3C'))\nRETURN\n  t.name AS therapy_name,\n  g.symbol AS gene_symbol,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 100\n", "generated_cypher": "MATCH (g:Gene {symbol: 'TUBA3C'})-[:VARIANT_OF]->(v:Variant)-[:VARIANT_OF]->(g)\nMATCH (g:Gene {symbol: 'TUBA3C'})-[:VARIANT_OF]->(v:Variant)\nMATCH (g:Gene {symbol: 'TUBA3C'})-[:VARIANT_OF]->(v:Variant)-[:TARGETS]->(t:Therapy)\nRETURN t.name AS therapy_name\nLIMIT 10", "gold_rows": [{"therapy_name": "Cabazitaxel", "gene_symbol": "TUBA3C", "targets_moa": "Tubulin inhibitor", "ref_sources": ["DailyMed", "Wikipedia"], "ref_ids": ["setid=de3d9c26-572b-4ea4-9b2d-dd58a2b3e8fa#nlm34090-1", "Taxane"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=de3d9c26-572b-4ea4-9b2d-dd58a2b3e8fa#nlm34090-1", "http://en.wikipedia.org/wiki/Taxane"]}, {"therapy_name": "Docetaxel", "gene_symbol": "TUBA3C", "targets_moa": "Tubulin inhibitor", "ref_sources": ["FDA", "Wikipedia"], "ref_ids": ["label/2014/201195s006lbl.pdf", "Microtubule"], "ref_urls": ["http://en.wikipedia.org/wiki/Microtubule", "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/201195s006lbl.pdf"]}, {"therapy_name": "Enfortumab Vedotin", "gene_symbol": "TUBA3C", "targets_moa": "Tubulin inhibitor", "ref_sources": ["Other", "PubMed", "PubMed", "PubMed"], "ref_ids": ["http://www.seattlegenetics.com/pipeline/enfortumab-vedotin", "27013195", "27518442", "28353637"], "ref_urls": ["http://europepmc.org/abstract/MED/27013195", "http://europepmc.org/abstract/MED/27518442", "http://europepmc.org/abstract/MED/28353637", "http://www.seattlegenetics.com/pipeline/enfortumab-vedotin"]}, {"therapy_name": "Eribulin", "gene_symbol": "TUBA3C", "targets_moa": "Tubulin inhibitor", "ref_sources": ["DailyMed", "PubMed"], "ref_ids": ["setid=31ce4750-ded5-4a0b-95e9-f229fa6bc822#nlm34090-1", "22619477"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=31ce4750-ded5-4a0b-95e9-f229fa6bc822#nlm34090-1", "http://europepmc.org/abstract/MED/22619477"]}, {"therapy_name": "Paclitaxel", "gene_symbol": "TUBA3C", "targets_moa": "Tubulin inhibitor", "ref_sources": ["DailyMed", "Wikipedia"], "ref_ids": ["setid=24d10449-2936-4cd3-b7db-a7683db721e4#section-15", "Microtubule"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=24d10449-2936-4cd3-b7db-a7683db721e4#section-15", "http://en.wikipedia.org/wiki/Microtubule"]}, {"therapy_name": "Taxol", "gene_symbol": "TUBA3C", "targets_moa": "Tubulin inhibitor", "ref_sources": ["DailyMed", "Wikipedia"], "ref_ids": ["setid=24d10449-2936-4cd3-b7db-a7683db721e4#section-15", "Microtubule"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=24d10449-2936-4cd3-b7db-a7683db721e4#section-15", "http://en.wikipedia.org/wiki/Microtubule"]}, {"therapy_name": "Trastuzumab Emtansine", "gene_symbol": "TUBA3C", "targets_moa": "Tubulin inhibitor", "ref_sources": ["DailyMed", "DailyMed", "PubMed", "PubMed", "PubMed"], "ref_ids": ["setid=23f3c1f4-0fc8-4804-a9e3-04cf25dd302e", "setid=23f3c1f4-0fc8-4804-a9e3-04cf25dd302e#nlm34090-1", "1241159", "22044006", "23798344"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=23f3c1f4-0fc8-4804-a9e3-04cf25dd302e", "http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=23f3c1f4-0fc8-4804-a9e3-04cf25dd302e#nlm34090-1", "http://europepmc.org/abstract/MED/1241159", "http://europepmc.org/abstract/MED/22044006", "http://europepmc.org/abstract/MED/23798344"]}, {"therapy_name": "Vincristine", "gene_symbol": "TUBA3C", "targets_moa": "Tubulin inhibitor", "ref_sources": ["DailyMed", "PubMed"], "ref_ids": ["setid=01cee93f-3ab9-44fa-8c9a-dd5958fd2db9", "22044006"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=01cee93f-3ab9-44fa-8c9a-dd5958fd2db9", "http://europepmc.org/abstract/MED/22044006"]}, {"therapy_name": "Vinorelbine", "gene_symbol": "TUBA3C", "targets_moa": "Tubulin inhibitor", "ref_sources": ["DailyMed", "PubMed", "PubMed"], "ref_ids": ["setid=6d47c96a-7fdc-48ac-9250-41c5d3ecf8db", "22044006", "22594474"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6d47c96a-7fdc-48ac-9250-41c5d3ecf8db", "http://europepmc.org/abstract/MED/22044006", "http://europepmc.org/abstract/MED/22594474"]}], "generated_rows": [], "error": null}
{"id": "F2.1-000090-P2", "question": "Describe how Ripretinib acts on KIT.", "gold_cypher": "MATCH (t:Therapy)-[r:TARGETS]->(g:Gene)\nWHERE (\n  toLower(t.name) = toLower('Ripretinib')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Ripretinib'))\n  OR toLower(t.name) CONTAINS toLower('Ripretinib')\n)\n  AND (\n    toLower(g.symbol) = toLower('KIT')\n    OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('KIT'))\n  )\nRETURN\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 100\n", "generated_cypher": "MATCH (g:Gene {symbol: 'kit'})-[:VARIANT_OF]->(v:Variant)\nWHERE v.name CONTAINS 'ripretinib' OR g.symbol CONTAINS 'kit'\nRETURN g.symbol AS gene_symbol, v.name AS variant_name, v.effect AS effect\nLIMIT 10", "gold_rows": [{"gene_symbol": "KIT", "therapy_name": "Ripretinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2020/213973s000lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213973s000lbl.pdf"]}], "generated_rows": [], "error": null}
{"id": "F2.1-000095-P1", "question": "What is the MOA of Afimoxifene on ESRRG?", "gold_cypher": "MATCH (t:Therapy)-[r:TARGETS]->(g:Gene)\nWHERE (\n  toLower(t.name) = toLower('Afimoxifene')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Afimoxifene'))\n  OR toLower(t.name) CONTAINS toLower('Afimoxifene')\n)\n  AND (\n    toLower(g.symbol) = toLower('ESRRG')\n    OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('ESRRG'))\n  )\nRETURN\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 100\n", "generated_cypher": "MATCH (g:Gene {symbol: 'ESRRG'})-[:VARIANT_OF]->(v:Variant)\nWHERE v.name CONTAINS 'afimoxifene'\nRETURN g.symbol AS gene_symbol, v.name AS variant_name, v.moa AS moa\nLIMIT 10", "gold_rows": [{"gene_symbol": "ESRRG", "therapy_name": "Afimoxifene", "targets_moa": "Estrogen-related receptor gamma antagonist", "ref_sources": ["KEGG", "PubMed", "Wikipedia"], "ref_ids": ["D06551", "11447273", "Afimoxifene"], "ref_urls": ["http://en.wikipedia.org/wiki/Afimoxifene", "http://europepmc.org/abstract/MED/11447273"]}], "generated_rows": [], "error": null}
{"id": "F5.1-000158-P1", "question": "Which biomarkers show evidence in Glioblastoma?", "gold_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'glioblastoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nRETURN\n  CASE WHEN b:Variant THEN b.name ELSE NULL END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "generated_cypher": "MATCH (b: Biomarker)-[:AFFECTS_RESPONSE_TO]->(t: Therapy)\nWHERE toLower(t.name) CONTAINS 'glioblastoma'\nRETURN b.name AS biomarker_name, b.effect, b.pmids\nORDER BY biomarker_name\nLIMIT 10", "gold_rows": [{"variant_name": "EGFR Expression", "gene_symbol": "EGFR", "therapy_name": "3-Dimensional Conformal Radiation Therapy", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["31289592"]}, {"variant_name": "ATRX Loss-of-function", "gene_symbol": "ATRX", "therapy_name": "Adavosertib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["34118569"]}, {"variant_name": "EGFR Amplification AND EGFR EGFRVIII", "gene_symbol": "EGFR", "therapy_name": "Afatinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["26423602"]}, {"variant_name": "EGFR G598V", "gene_symbol": "EGFR", "therapy_name": "Afatinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["32226941"]}, {"variant_name": "EGFR VIII", "gene_symbol": "EGFR", "therapy_name": "Afatinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["32226941"]}, {"variant_name": "EGFR EGFR::WIF1 Fusion", "gene_symbol": "EGFR", "therapy_name": "Bevacizumab", "effect": "sensitivity", "disease_name": "IDH-wildtype Glioblastoma", "pmids": ["26762204"]}, {"variant_name": "EGFR Overexpression", "gene_symbol": "EGFR", "therapy_name": "Bevacizumab", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["26762204"]}, {"variant_name": "VEGFA Overexpression", "gene_symbol": "VEGFA", "therapy_name": "Bevacizumab", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["18182667"]}, {"variant_name": "VEGFA Overexpression of VEGF121", "gene_symbol": "VEGFA", "therapy_name": "Bevacizumab", "effect": "resistance", "disease_name": "Glioblastoma", "pmids": ["29747600"]}, {"variant_name": "EGFR EGFR::VSTM2A Fusion", "gene_symbol": "EGFR", "therapy_name": "Bevacizumab/Lomustine Regimen", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["26762204"]}, {"variant_name": "PIK3CA Mutation", "gene_symbol": "PIK3CA", "therapy_name": "Buparlisib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["30715997"]}, {"variant_name": "PIK3R1 Mutation", "gene_symbol": "PIK3R1", "therapy_name": "Buparlisib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["30715997"]}, {"variant_name": "PTEN Mutation", "gene_symbol": "PTEN", "therapy_name": "Buparlisib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["30715997"]}, {"variant_name": "MGMT Promoter Methylation", "gene_symbol": "MGMT", "therapy_name": "Carmustine", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["11070098"]}, {"variant_name": "IDH1 R132", "gene_symbol": "IDH1", "therapy_name": "Cetuximab", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["22199315"]}, {"variant_name": "IDH1 R132S", "gene_symbol": "IDH1", "therapy_name": "Cetuximab", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["22199315"]}, {"variant_name": "ALK Expression", "gene_symbol": "ALK", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["26498130"]}, {"variant_name": "MET Amplification", "gene_symbol": "MET", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["22162573"]}, {"variant_name": "PTEN Expression", "gene_symbol": "PTEN", "therapy_name": "Dacomitinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["25939761"]}, {"variant_name": "DRD5 low expression", "gene_symbol": "DRD5", "therapy_name": "Dordaviprone", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["30559168"]}, {"variant_name": "CSF1R Expression", "gene_symbol": "CSF1R", "therapy_name": "Dovitinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["28759044"]}, {"variant_name": "BCR BCR::NTRK2 Fusion", "gene_symbol": "BCR", "therapy_name": "Entrectinib", "effect": "sensitivity", "disease_name": "Brain Glioblastoma Multiforme", "pmids": ["35673607"]}, {"variant_name": "ETV6 ETV6::NTRK3 Fusion", "gene_symbol": "ETV6", "therapy_name": "Entrectinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["35395680"]}, {"variant_name": "EGFR VIII", "gene_symbol": "EGFR", "therapy_name": "Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["16282176"]}, {"variant_name": "PTEN Expression", "gene_symbol": "PTEN", "therapy_name": "Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["16282176"]}, {"variant_name": "EGFR EGFR::SEPTIN14 Fusion", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["23917401"]}, {"variant_name": "EGFR G598V", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["32226941"]}, {"variant_name": "EGFR VIII", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["16282176"]}, {"variant_name": "PTEN Expression", "gene_symbol": "PTEN", "therapy_name": "Erlotinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["16282176"]}, {"variant_name": "FGFR1 FGFR1::TACC1 Fusion", "gene_symbol": "FGFR1", "therapy_name": "Futibatinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["34551969"]}, {"variant_name": "EGFR VIII", "gene_symbol": "EGFR", "therapy_name": "Gefitinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["16282176"]}, {"variant_name": "PTEN Expression", "gene_symbol": "PTEN", "therapy_name": "Gefitinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["16282176"]}, {"variant_name": "ROS1 Overexpression", "gene_symbol": "ROS1", "therapy_name": "Gefitinib", "effect": "resistance", "disease_name": "Glioblastoma", "pmids": ["25978031"]}, {"variant_name": "EGFR EGFR::SEPTIN14 Fusion", "gene_symbol": "EGFR", "therapy_name": "Lapatinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["23917401"]}, {"variant_name": "EGFR G598V", "gene_symbol": "EGFR", "therapy_name": "Lapatinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["32226941"]}, {"variant_name": "KANK1 KANK1::NTRK2 Fusion", "gene_symbol": "KANK1", "therapy_name": "Larotrectinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["34041811"]}, {"variant_name": "EGFR Overexpression", "gene_symbol": "EGFR", "therapy_name": "Lomustine", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["26762204"]}, {"variant_name": "MGMT Promoter Methylation", "gene_symbol": "MGMT", "therapy_name": "Lomustine", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["30782343"]}, {"variant_name": "GOPC GOPC::ROS1 e7::e35", "gene_symbol": "GOPC", "therapy_name": "Lorlatinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["30171048"]}, {"variant_name": "TP53 M237I", "gene_symbol": "TP53", "therapy_name": "MDM2 Inhibitor AMGMDS3", "effect": "resistance", "disease_name": "Glioblastoma", "pmids": ["25730903"]}, {"variant_name": "HGF EXPRESSION", "gene_symbol": "HGF", "therapy_name": "MET Tyrosine Kinase Inhibitor SGX523", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["22203985"]}, {"variant_name": "MDM2 Amplification", "gene_symbol": "MDM2", "therapy_name": "Navtemadlin", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["30022047"]}, {"variant_name": "EGFR Expression", "gene_symbol": "EGFR", "therapy_name": "Nimotuzumab", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["31289592"]}, {"variant_name": "PMS2 K706FS*19", "gene_symbol": "PMS2", "therapy_name": "Nivolumab", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["27001570"]}, {"variant_name": "PTEN Mutation", "gene_symbol": "PTEN", "therapy_name": "Nivolumab", "effect": "resistance", "disease_name": "Glioblastoma", "pmids": ["30742119"]}, {"variant_name": "MGMT Promoter Methylation", "gene_symbol": "MGMT", "therapy_name": "O6-Benzylguanine", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["11070098"]}, {"variant_name": "ATRX Loss-of-function", "gene_symbol": "ATRX", "therapy_name": "Olaparib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["34118569"]}, {"variant_name": "BRCA2 K3326*", "gene_symbol": "BRCA2", "therapy_name": "Olaparib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["32043779"]}, {"variant_name": "EGFR G598V", "gene_symbol": "EGFR", "therapy_name": "Osimertinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["32226941"]}, {"variant_name": "EGFR G598V", "gene_symbol": "EGFR", "therapy_name": "Pacritinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["32226941"]}, {"variant_name": "EGFR VIII", "gene_symbol": "EGFR", "therapy_name": "Pacritinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["32226941"]}, {"variant_name": "CDK6 Amplification", "gene_symbol": "CDK6", "therapy_name": "Palbociclib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["20354191"]}, {"variant_name": "CDK6 Overexpression", "gene_symbol": "CDK6", "therapy_name": "Palbociclib", "effect": "sensitivity", "disease_name": "Glioblastoma Proneural Subtype", "pmids": ["28903422"]}, {"variant_name": "CDKN2A Loss", "gene_symbol": "CDKN2A", "therapy_name": "Palbociclib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["22711607"]}, {"variant_name": "RB1 Loss-of-function", "gene_symbol": "RB1", "therapy_name": "Palbociclib", "effect": "resistance", "disease_name": "Glioblastoma", "pmids": ["20354191"]}, {"variant_name": "IDH1 R132H", "gene_symbol": "IDH1", "therapy_name": "Pan-Mutant-IDH1 Inhibitor Bay-1436032", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["21045145"]}, {"variant_name": "POLE Mutation", "gene_symbol": "POLE", "therapy_name": "Pembrolizumab", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["27683556"]}, {"variant_name": "PTEN Mutation", "gene_symbol": "PTEN", "therapy_name": "Pembrolizumab", "effect": "resistance", "disease_name": "Glioblastoma", "pmids": ["30742119"]}, {"variant_name": "CSF1R Expression", "gene_symbol": "CSF1R", "therapy_name": "Pexidartinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["28759044"]}, {"variant_name": "ATRX Loss-of-function", "gene_symbol": "ATRX", "therapy_name": "Pyridostatin", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["34118569"]}, {"variant_name": "MDM2 Amplification", "gene_symbol": "MDM2", "therapy_name": "RG7112", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["30022047"]}, {"variant_name": "EGFR VIII", "gene_symbol": "EGFR", "therapy_name": "Rindopepimut", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["25586468"]}, {"variant_name": "KIT EXPRESSION", "gene_symbol": "KIT", "therapy_name": "Sunitinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["24311637"]}, {"variant_name": "ATRX Loss-of-function", "gene_symbol": "ATRX", "therapy_name": "Talazoparib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["34118569"]}, {"variant_name": "EGFR Amplification", "gene_symbol": "EGFR", "therapy_name": "Talazoparib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["31852834"]}, {"variant_name": "ATM Mutation", "gene_symbol": "ATM", "therapy_name": "Temozolomide", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["23960094"]}, {"variant_name": "BRCA2 K3326*", "gene_symbol": "BRCA2", "therapy_name": "Temozolomide", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["32043779"]}, {"variant_name": "EGFR Expression", "gene_symbol": "EGFR", "therapy_name": "Temozolomide", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["31289592"]}, {"variant_name": "MGMT Promoter Methylation", "gene_symbol": "MGMT", "therapy_name": "Temozolomide", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["30782343"]}, {"variant_name": "MGMT RS16906252", "gene_symbol": "MGMT", "therapy_name": "Temozolomide", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["25910840"]}, {"variant_name": "MGMT Underexpression", "gene_symbol": "MGMT", "therapy_name": "Temozolomide", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["21331613"]}, {"variant_name": "TP53 M237I", "gene_symbol": "TP53", "therapy_name": "Temozolomide", "effect": "resistance", "disease_name": "Glioblastoma", "pmids": ["24248532"]}, {"variant_name": "TP53 Mutation", "gene_symbol": "TP53", "therapy_name": "Temozolomide", "effect": "resistance", "disease_name": "Glioblastoma", "pmids": ["24248532"]}, {"variant_name": "TP53 R273H", "gene_symbol": "TP53", "therapy_name": "Temozolomide", "effect": "resistance", "disease_name": "Glioblastoma", "pmids": ["24248532"]}, {"variant_name": "CSF1R Expression", "gene_symbol": "CSF1R", "therapy_name": "Vatalanib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["28759044"]}, {"variant_name": "BRAF V600E", "gene_symbol": "BRAF", "therapy_name": "Vemurafenib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["24725538"]}], "generated_rows": [], "error": null}
{"id": "F5.1-000175", "question": "In Malignant Anus Melanoma, which biomarkers have evidence?", "gold_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'malignant' AND\n    toLower(rel.disease_name) CONTAINS 'anus' AND\n    toLower(rel.disease_name) CONTAINS 'melanoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nRETURN\n  CASE WHEN b:Variant THEN b.name ELSE NULL END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "generated_cypher": "MATCH (b:Biomarker)\nWHERE EXISTS {\n  (b)-[:AFFECTS_RESPONSE_TO]->(t:Therapy)\n  WHERE t.name CONTAINS 'melanoma' OR t.name CONTAINS 'anus'\n}\nRETURN b.name AS biomarker_name, \n       coalesce(b.effect, []) AS effect,\n       coalesce(b.pmids, []) AS pmids,\n       coalesce(b.ref_sources, []) AS ref_sources,\n       coalesce(b.ref_ids, []) AS ref_ids,\n       coalesce(b.ref_urls, []) AS ref_urls\nLIMIT 10", "gold_rows": [{"variant_name": "KIT Internal Duplication", "gene_symbol": "KIT", "therapy_name": "Imatinib", "effect": "sensitivity", "disease_name": "Malignant Anus Melanoma", "pmids": ["18421059"]}], "generated_rows": [], "error": null}
{"id": "F5.1-000018-P3", "question": "What biomarkers have therapy response evidence in B-cell Non-Hodgkin Lymphoma?", "gold_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'b-cell' AND\n    toLower(rel.disease_name) CONTAINS 'non-hodgkin' AND\n    toLower(rel.disease_name) CONTAINS 'lymphoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nRETURN\n  CASE WHEN b:Variant THEN b.name ELSE NULL END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "generated_cypher": "MATCH (b: Biomarker)-[:AFFECTS_RESPONSE_TO]->(t: Therapy)\nWHERE toLower(t.name) CONTAINS 'b-cell non-hodgkin lymphoma'\nRETURN b.name AS biomarker, t.name AS therapy\nLIMIT 10", "gold_rows": [{"variant_name": "CD80 Overexpression", "gene_symbol": "CD80", "therapy_name": "Cisplatin", "effect": "sensitivity", "disease_name": "B-cell Non-Hodgkin Lymphoma", "pmids": ["22267549"]}, {"variant_name": "CD80 Overexpression", "gene_symbol": "CD80", "therapy_name": "Galiximab", "effect": "sensitivity", "disease_name": "B-cell Non-Hodgkin Lymphoma", "pmids": ["22267549"]}], "generated_rows": [], "error": null}
{"id": "F6.1-000125-S1-P1", "question": "In Naevocarcinoma, which genes confer resistance to Vemurafenib or Dabrafenib?", "gold_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Vemurafenib')\n  OR toLower(t.name) = toLower('Dabrafenib')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Vemurafenib'))\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Dabrafenib'))\n  OR toLower(t.name) CONTAINS toLower('Vemurafenib')\n  OR toLower(t.name) CONTAINS toLower('Dabrafenib')\n)\nAND toLower(rel.effect) = 'resistance'\nAND (\n    toLower(rel.disease_name) CONTAINS 'melanoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  'resistance' AS effect,\n  disease_name,\n  pmids\nLIMIT 100\n", "generated_cypher": "MATCH (g:Gene), (v:Variant)-[:VARIANT_OF]->(g), (t:Therapy {name: 'Vemurafenib'}), (t2:Therapy {name: 'Dabrafenib'})\nWHERE toLower(g.symbol) IN [\n    'braf', 'braf1', 'braf2', 'braf-a', 'braf-b', 'braf-1', 'braf-2', 'braf-a1', 'braf-a2'\n]\nWITH g, v\nWHERE toLower(t.name) IN ['vemurafenib', 'dabrafenib']\n  AND toLower(t2.name) IN ['vemurafenib', 'dabrafenib']\n  AND g.symbol IN [\n    'braf'\n  ]\n  AND (v.effect CONTAINS 'resistance' OR v.effect CONTAINS 'resistant')\n  AND g.symbol IN [\n    'braf'\n  ]\nRETURN DISTINCT g.symbol AS gene_symbol, v.name AS variant_name, v.effect AS resistance_effect\nORDER BY gene_symbol, variant_name\nLIMIT 10", "gold_rows": [{"variant_name": null, "gene_symbol": "AKT1", "therapy_name": "Dabrafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24265155"]}, {"variant_name": null, "gene_symbol": "ATXN1L", "therapy_name": "Dabrafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["28178529"]}, {"variant_name": null, "gene_symbol": "BRAF", "therapy_name": "Dabrafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24265155", "24055054", "25452114", "23237741"]}, {"variant_name": null, "gene_symbol": "BRAF", "therapy_name": "Dabrafenib", "effect": "resistance", "disease_name": "Skin Melanoma", "pmids": ["23237741"]}, {"variant_name": null, "gene_symbol": "CDKN2A", "therapy_name": "Dabrafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24265155"]}, {"variant_name": null, "gene_symbol": "HOXD8", "therapy_name": "Dabrafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24265153"]}, {"variant_name": null, "gene_symbol": "KRAS", "therapy_name": "Dabrafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24265155"]}, {"variant_name": null, "gene_symbol": "MAP2K1", "therapy_name": "Dabrafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24265153"]}, {"variant_name": null, "gene_symbol": "MAP2K2", "therapy_name": "Dabrafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["25452114", "24265153"]}, {"variant_name": null, "gene_symbol": "MITF", "therapy_name": "Dabrafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24265153"]}, {"variant_name": null, "gene_symbol": "NF1", "therapy_name": "Dabrafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["23171796"]}, {"variant_name": null, "gene_symbol": "NRAS", "therapy_name": "Dabrafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24265155", "25452114"]}, {"variant_name": null, "gene_symbol": "RAC1", "therapy_name": "Dabrafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24265153", "25056119"]}, {"variant_name": null, "gene_symbol": "AEBP1", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Skin Melanoma", "pmids": ["24201813"]}, {"variant_name": null, "gene_symbol": "AGK", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["23890088"]}, {"variant_name": null, "gene_symbol": "AKT1", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24265155", "24265152"]}, {"variant_name": null, "gene_symbol": "AKT3", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24265155"]}, {"variant_name": null, "gene_symbol": "ATXN1L", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["28178529"]}, {"variant_name": null, "gene_symbol": "BRAF", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24265155", "26070258", "25515853", "24112705", "24055054", "24576830", "22113612"]}, {"variant_name": null, "gene_symbol": "BRAF", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Skin Melanoma", "pmids": ["23237741"]}, {"variant_name": null, "gene_symbol": "CDKN2A", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24265155"]}, {"variant_name": null, "gene_symbol": "CIC", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["28178529"]}, {"variant_name": null, "gene_symbol": "FGFR3", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Skin Melanoma", "pmids": ["21107323"]}, {"variant_name": null, "gene_symbol": "GNAQ", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Skin Melanoma", "pmids": ["24504448"]}, {"variant_name": null, "gene_symbol": "HOXD8", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24265153"]}, {"variant_name": null, "gene_symbol": "KRAS", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24265155"]}, {"variant_name": null, "gene_symbol": "MAP2K1", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["21383288", "23569304", "24265153"]}, {"variant_name": null, "gene_symbol": "MAP2K2", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24265153"]}, {"variant_name": null, "gene_symbol": "MET", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Skin Melanoma", "pmids": ["26359985", "23802768"]}, {"variant_name": null, "gene_symbol": "MITF", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24265153"]}, {"variant_name": null, "gene_symbol": "NF1", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Skin Melanoma", "pmids": ["23288408", "23171796"]}, {"variant_name": null, "gene_symbol": "NF1", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["23288408"]}, {"variant_name": null, "gene_symbol": "NRAS", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24265155", "23569304", "21107323", "22395615", "20149136", "28783719"]}, {"variant_name": null, "gene_symbol": "NRAS", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Skin Melanoma", "pmids": ["23948972", "22194965"]}, {"variant_name": null, "gene_symbol": "PAPSS1", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24345920"]}, {"variant_name": null, "gene_symbol": "PIK3CA", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24265155"]}, {"variant_name": null, "gene_symbol": "PIK3R2", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24265155"]}, {"variant_name": null, "gene_symbol": "PREX2", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24265155"]}, {"variant_name": null, "gene_symbol": "PTEN", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24265155"]}, {"variant_name": null, "gene_symbol": "RAC1", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24265153", "25056119"]}, {"variant_name": null, "gene_symbol": "RAF1", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["27273450"]}, {"variant_name": null, "gene_symbol": "SOX10", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24670642"]}, {"variant_name": null, "gene_symbol": "STAG2", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["27500726"]}, {"variant_name": null, "gene_symbol": "STAG3", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["27500726"]}, {"variant_name": null, "gene_symbol": "TF", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24265155"]}, {"variant_name": null, "gene_symbol": "TRIM24", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Skin Melanoma", "pmids": ["24345920"]}], "generated_rows": [], "error": null}
{"id": "F6.4-000002-P2", "question": "Which treatments target resistance biomarkers for Pemetrexed in Lung Non-small Cell Carcinoma?", "gold_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t1:Therapy)\nWHERE (\n  toLower(t1.name) = toLower('Pemetrexed')\n  OR any(s IN coalesce(t1.synonyms, []) WHERE toLower(s) = toLower('Pemetrexed'))\n  OR toLower(t1.name) CONTAINS toLower('Pemetrexed')\n)\n  AND toLower(rel.effect) = 'resistance'\n  AND (\n    toLower(rel.disease_name) CONTAINS 'lung' AND\n    toLower(rel.disease_name) CONTAINS 'non-small' AND\n    toLower(rel.disease_name) CONTAINS 'cell' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol\nWHERE gene_symbol IS NOT NULL\nMATCH (t2:Therapy)-[r:TARGETS]->(tg:Gene)\nWHERE (\n  toLower(tg.symbol) = toLower(gene_symbol)\n  OR any(s IN coalesce(tg.synonyms, []) WHERE toLower(s) = toLower(gene_symbol))\n)\n  AND toLower(t2.name) <> toLower('Pemetrexed')\nRETURN\n  gene_symbol,\n  t2.name AS therapy_name,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 100\n", "generated_cypher": "MATCH (gene:Gene), (variant:Variant), (therapy:Therapy), (biomarker:Biomarker)\nWHERE toLower(gene.symbol) CONTAINS 'pemetrexed' \n  AND (variant)-[:VARIANT_OF]->(gene)\n  AND (biomarker)-[:AFFECTS_RESPONSE_TO]->(therapy)\n  AND toLower(therapy.name) CONTAINS 'resistance'\n  AND toLower(biomarker.name) CONTAINS 'resistance'\n  AND (gene.name = 'EGFR' OR gene.name = 'KRAS' OR gene.name = 'ALK' OR gene.name = 'PD-L1')\n  AND (variant.name CONTAINS 'resistance' OR variant.name CONTAINS 'mutation')\n  AND (therapy.name CONTAINS 'targeted' OR therapy.name CONTAINS 'inhibitor')\n  AND toLower(biomarker.disease_name) CONTAINS 'lung non-small cell carcinoma'\nRETURN therapy.name AS therapy_name, biomarker.name AS biomarker_name, gene.symbol AS gene_symbol\nORDER BY therapy.name\nLIMIT 10", "gold_rows": [{"gene_symbol": "TYMS", "therapy_name": "Capecitabine", "targets_moa": "Thymidylate synthase inhibitor", "ref_sources": ["DailyMed", "PubMed"], "ref_ids": ["setid=a1de8bba-3b1d-4c9d-ab8a-32d2c05e67c8#section-13", "12724731"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a1de8bba-3b1d-4c9d-ab8a-32d2c05e67c8#section-13", "http://europepmc.org/abstract/MED/12724731"]}, {"gene_symbol": "TYMS", "therapy_name": "Fluorouracil", "targets_moa": "Thymidylate synthase inhibitor", "ref_sources": ["DailyMed", "PubMed"], "ref_ids": ["setid=b90e0da7-f702-4f09-9488-74f2bb20e9ac", "12724731"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b90e0da7-f702-4f09-9488-74f2bb20e9ac", "http://europepmc.org/abstract/MED/12724731"]}, {"gene_symbol": "TYMS", "therapy_name": "Raltitrexed", "targets_moa": "Thymidylate synthase inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["12056700", "9579851"], "ref_urls": ["http://europepmc.org/abstract/MED/12056700", "http://europepmc.org/abstract/MED/9579851"]}, {"gene_symbol": "TYMS", "therapy_name": "Tegafur", "targets_moa": "Thymidylate synthase inhibitor", "ref_sources": ["EMA"], "ref_ids": ["https://www.ema.europa.eu/en/documents/product-information/teysuno-epar-product-information_en.pdf"], "ref_urls": ["https://www.ema.europa.eu/en/documents/product-information/teysuno-epar-product-information_en.pdf"]}], "generated_rows": [], "error": null}
{"id": "F2.3-000195", "question": "Provide PMIDs supporting that ERBB2 Amplification confers sensitivity to Margetuximab.", "gold_cypher": "MATCH (v:Variant {name: 'ERBB2 Amplification'})-[:VARIANT_OF]->(g:Gene)\nMATCH (v)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Margetuximab')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Margetuximab'))\n  OR toLower(t.name) CONTAINS toLower('Margetuximab')\n)\nAND toLower(rel.effect) = 'sensitivity'\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  'sensitivity' AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "generated_cypher": "MATCH (g:Gene {symbol: 'ERBB2'})-[:VARIANT_OF]->(v:Variant)\nWHERE toLower(v.name) CONTAINS 'amplification'\nMATCH (t:Therapy {name: 'Margetuximab'})-[:TARGETS]->(g)\nWITH g, v, t\nOPTIONAL MATCH (g)-[:AFFECTS_RESPONSE_TO]->(b:Biomarker)\nWHERE b.name CONTAINS 'erbb2' OR b.name CONTAINS 'amplification'\nWITH g, v, t, b\nOPTIONAL MATCH (g)-[:VARIANT_OF]->(v)\nWHERE v.name CONTAINS 'amplification'\nWITH t, g, v, b\nRETURN coalesce(t.pmids, []) AS pmids\nLIMIT 10", "gold_rows": [{"variant_name": "ERBB2 Amplification", "gene_symbol": "ERBB2", "therapy_name": "Margetuximab", "effect": "sensitivity", "disease_name": "Breast Cancer", "pmids": ["33480963"]}], "generated_rows": [], "error": null}
{"id": "F2.3-000182-P2", "question": "What PubMed IDs support sensitivity of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor due to KRAS G12C?", "gold_cypher": "MATCH (v:Variant {name: 'KRAS G12C'})-[:VARIANT_OF]->(g:Gene)\nMATCH (v)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor'))\n  OR toLower(t.name) CONTAINS toLower('Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor')\n)\nAND toLower(rel.effect) = 'sensitivity'\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  'sensitivity' AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "generated_cypher": "MATCH (g:Gene), (v:Variant), (t:Therapy)\nWHERE toLower(g.symbol) = 'kras' \n  AND toLower(v.name) = 'g12c'\n  AND toLower(t.name) = 'epidermal growth factor receptor tyrosine kinase inhibitor'\n  AND EXISTS((v)-[:VARIANT_OF]->(g))\n  AND EXISTS((t)-[:TARGETS]->(g))\nRETURN coalesce(collect(distinct v.pmids), []) as pmids\nLIMIT 10", "gold_rows": [{"variant_name": "KRAS G12C", "gene_symbol": "KRAS", "therapy_name": "Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor", "effect": "sensitivity", "disease_name": "Cancer", "pmids": ["26739882"]}], "generated_rows": [{"pmids": []}], "error": null}
{"id": "F2.2-000147-P2", "question": "List genes associated with sensitivity to Mocetinostat in Breast Cancer.", "gold_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Mocetinostat')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Mocetinostat'))\n  OR toLower(t.name) CONTAINS toLower('Mocetinostat')\n)\nAND toLower(rel.effect) = 'sensitivity'\nAND (\n    toLower(rel.disease_name) CONTAINS 'breast'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  'sensitivity' AS effect,\n  disease_name,\n  pmids\nLIMIT 100\n", "generated_cypher": "MATCH (g:Gene)-[:VARIANT_OF]->(v:Variant)-[:VARIANT_OF]->(g)\nWHERE EXISTS {\n  (v)-[:VARIANT_OF]->(g)\n}\nWITH g, g.symbol AS gene_symbol\nMATCH (t:Therapy {name: 'Mocetinostat'})\nWHERE toLower(t.name) CONTAINS 'mocetinostat'\nMATCH (t)-[:TARGETS]->(g)\nWHERE toLower(g.name) CONTAINS 'breast cancer'\nRETURN g.name AS gene_name, g.symbol AS gene_symbol\nLIMIT 10", "gold_rows": [{"variant_name": null, "gene_symbol": "HDAC2", "therapy_name": "Mocetinostat", "effect": "sensitivity", "disease_name": "Breast Cancer", "pmids": ["28560068"]}], "generated_rows": [], "error": null}
{"id": "F2.2-000054", "question": "Which genes predict sensitivity to RG7112 in Glioblastoma?", "gold_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('RG7112')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('RG7112'))\n  OR toLower(t.name) CONTAINS toLower('RG7112')\n)\nAND toLower(rel.effect) = 'sensitivity'\nAND (\n    toLower(rel.disease_name) CONTAINS 'glioblastoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  'sensitivity' AS effect,\n  disease_name,\n  pmids\nLIMIT 100\n", "generated_cypher": "MATCH (g:Gene), (v:Variant)-[:VARIANT_OF]->(g), (t:Therapy {name: 'RG7112'}) \nWHERE toLower(g.symbol) IN [\n  'IDH1', 'IDH2', 'TP53', 'ATRX', 'MGMT'\n]\nWITH g, t\nWHERE EXISTS (\n  (v)-[:VARIANT_OF]->(g)\n)\nAND t.name = 'RG7112'\nAND EXISTS (\n  (g)-[:TARGETS]->(t)\n)\nRETURN g.symbol AS gene_symbol, g.name AS gene_name\nLIMIT 10", "gold_rows": [{"variant_name": null, "gene_symbol": "MDM2", "therapy_name": "RG7112", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["30022047"]}], "generated_rows": [], "error": null}
{"id": "F2.2-000064-P2", "question": "Which genes influence response to MTOR Kinase Inhibitor AZD8055 for Breast Cancer?", "gold_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('MTOR Kinase Inhibitor AZD8055')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('MTOR Kinase Inhibitor AZD8055'))\n  OR toLower(t.name) CONTAINS toLower('MTOR Kinase Inhibitor AZD8055')\n)\nAND (\n    toLower(rel.disease_name) CONTAINS 'breast'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  NULL AS effect,\n  disease_name,\n  pmids\nLIMIT 100\n", "generated_cypher": "MATCH (g:Gene), (v:Variant), (t:Therapy)\nWHERE toLower(t.name) CONTAINS 'azd8055'\n  AND toLower(t.name) CONTAINS 'mtor kinase inhibitor'\n  AND t.name = 'AZD8055'\n  AND (v)-[:VARIANT_OF]->(g)\n  AND (t)-[:TARGETS]->(g)\n  AND EXISTS {\n    (g)-[:AFFECTS_RESPONSE_TO]->(t)\n  }\nRETURN g.symbol AS gene_symbol, g.name AS gene_name\nORDER BY gene_symbol\nLIMIT 10", "gold_rows": [{"variant_name": null, "gene_symbol": "MTOR", "therapy_name": "MTOR Kinase Inhibitor AZD8055", "effect": null, "disease_name": "Breast Cancer", "pmids": ["27279227"]}], "generated_rows": [], "error": null}
{"id": "F2.2-000038-S1-P2", "question": "Which genes influence response to Vemurafenib for Childhood Ganglioglioma?", "gold_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Vemurafenib')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Vemurafenib'))\n  OR toLower(t.name) CONTAINS toLower('Vemurafenib')\n)\nAND (\n    toLower(rel.disease_name) CONTAINS 'ganglioglioma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  NULL AS effect,\n  disease_name,\n  pmids\nLIMIT 100\n", "generated_cypher": "MATCH (g:Gene), (v:Variant)-[:VARIANT_OF]->(g), (t:Therapy {name: 'Vemurafenib'})\nWHERE toLower(g.symbol) IN [\n  'braf', 'braf', 'braf', 'braf'\n]\nWITH g, v\nMATCH (d:Disease {name: 'Childhood Ganglioglioma'})\nWHERE toLower(d.name) CONTAINS 'ganglioglioma'\nRETURN g.symbol AS gene_symbol, v.name AS variant_name, d.name AS disease_name\nLIMIT 10", "gold_rows": [{"variant_name": null, "gene_symbol": "BRAF", "therapy_name": "Vemurafenib", "effect": null, "disease_name": "Ganglioglioma", "pmids": ["26579623", "31985841", "30120137"]}], "generated_rows": [], "error": null}
{"id": "F2.3-000121-P3", "question": "Give PMIDs for PRPS1 D183E-mediated resistance to Thioguanine.", "gold_cypher": "MATCH (v:Variant {name: 'PRPS1 D183E'})-[:VARIANT_OF]->(g:Gene)\nMATCH (v)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Thioguanine')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Thioguanine'))\n  OR toLower(t.name) CONTAINS toLower('Thioguanine')\n)\nAND toLower(rel.effect) = 'resistance'\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  'resistance' AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "generated_cypher": "MATCH (g:Gene {symbol: 'PRPS1'})-[:VARIANT_OF]->(v:Variant {name: 'D183E'})-[:AFFECTS_RESPONSE_TO]->(t:Therapy {name: 'Thioguanine'})\nRETURN coalesce(v.pmids, []) as pmids\nLIMIT 10", "gold_rows": [{"variant_name": "PRPS1 D183E", "gene_symbol": "PRPS1", "therapy_name": "Thioguanine", "effect": "resistance", "disease_name": "B-lymphoblastic Leukemia/lymphoma", "pmids": ["25962120"]}], "generated_rows": [], "error": null}
{"id": "F2.3-000165-P2", "question": "What PMIDs support resistance of Axitinib due to BCR BCR::ABL1 Fusion AND ABL1 F311I?", "gold_cypher": "MATCH (v:Variant {name: 'BCR BCR::ABL1 Fusion AND ABL1 F311I'})-[:VARIANT_OF]->(g:Gene)\nMATCH (v)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Axitinib')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Axitinib'))\n  OR toLower(t.name) CONTAINS toLower('Axitinib')\n)\nAND toLower(rel.effect) = 'resistance'\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  'resistance' AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "generated_cypher": "MATCH (g:Gene), (v:Variant), (d:Disease)\nWHERE v.name CONTAINS 'ABL1 F311I'\n  AND g.symbol = 'ABL1'\n  AND v.variant_of = g.symbol\n  AND (d.name CONTAINS 'BCR::ABL1' OR d.name CONTAINS 'BCR BCR::ABL1')\n  AND EXISTS {\n    (v)-[:VARIANT_OF]->(g)\n  }\n  AND EXISTS {\n    (g)-[:TARGETS]->(t:Therapy {name: 'Axitinib'})\n  }\n  AND EXISTS {\n    (t)-[:AFFECTS_RESPONSE_TO]->(b:Biomarker)\n  }\nRETURN coalesce(v.pmids, []) AS pmids\nLIMIT 10", "gold_rows": [{"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 F311I", "gene_symbol": "BCR", "therapy_name": "Axitinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["26582647"]}], "generated_rows": [], "error": null}
{"id": "F1.2-000166-P2", "question": "List genes that Fedratinib targets.", "gold_cypher": "MATCH (t:Therapy)-[r:TARGETS]->(g:Gene)\nWHERE (\n  toLower(t.name) = toLower('Fedratinib')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Fedratinib'))\n  OR toLower(t.name) CONTAINS toLower('Fedratinib')\n)\nRETURN\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 100\n", "generated_cypher": "MATCH (g:Gene)\nWHERE EXISTS {\n  (g)-[:TARGETS]->(t:Therapy)\n  WHERE toLower(t.name) CONTAINS 'fedratinib'\n}\nRETURN g.symbol AS gene_symbol\nLIMIT 100", "gold_rows": [{"gene_symbol": "FLT3", "therapy_name": "Fedratinib", "targets_moa": "Tyrosine-protein kinase receptor FLT3 inhibitor", "ref_sources": ["FDA", "PubMed"], "ref_ids": ["label/2019/212327s000lbl.pdf", "18394554"], "ref_urls": ["http://europepmc.org/abstract/MED/18394554", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212327s000lbl.pdf"]}, {"gene_symbol": "JAK2", "therapy_name": "Fedratinib", "targets_moa": "Tyrosine-protein kinase JAK2 inhibitor", "ref_sources": ["FDA", "PubMed"], "ref_ids": ["label/2019/212327s000lbl.pdf", "18394554"], "ref_urls": ["http://europepmc.org/abstract/MED/18394554", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212327s000lbl.pdf"]}], "generated_rows": [], "error": null}
{"id": "F1.2-000035", "question": "Which genes does Decitabine target?", "gold_cypher": "MATCH (t:Therapy)-[r:TARGETS]->(g:Gene)\nWHERE (\n  toLower(t.name) = toLower('Decitabine')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Decitabine'))\n  OR toLower(t.name) CONTAINS toLower('Decitabine')\n)\nRETURN\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 100\n", "generated_cypher": "MATCH (g:Gene), (v:Variant)-[:VARIANT_OF]->(g)\nWHERE v.name = 'Decitabine'\nRETURN g.symbol AS gene_symbol\nLIMIT 10", "gold_rows": [{"gene_symbol": "DNMT1", "therapy_name": "Decitabine", "targets_moa": "DNA (cytosine-5)-methyltransferase 1 inhibitor", "ref_sources": ["DailyMed", "Wikipedia"], "ref_ids": ["setid=acaf6e50-7cd3-4431-98ef-d1c07e3ed8c2#section-13", "DNA_methylation"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=acaf6e50-7cd3-4431-98ef-d1c07e3ed8c2#section-13", "http://en.wikipedia.org/wiki/DNA_methylation"]}, {"gene_symbol": "DNMT3A", "therapy_name": "Decitabine", "targets_moa": "DNA (cytosine-5)-methyltransferase 3A inhibitor", "ref_sources": ["DailyMed", "Wikipedia"], "ref_ids": ["setid=acaf6e50-7cd3-4431-98ef-d1c07e3ed8c2#section-13", "DNA_methylation"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=acaf6e50-7cd3-4431-98ef-d1c07e3ed8c2#section-13", "http://en.wikipedia.org/wiki/DNA_methylation"]}], "generated_rows": [], "error": null}
{"id": "F6.2-000056-P1", "question": "Which drugs hit TOP1 but not KDR with evidence in Ureter Small Cell Carcinoma?", "gold_cypher": "MATCH (t:Therapy)-[:TARGETS]->(gi:Gene)\nWHERE toLower(gi.symbol) = toLower('TOP1')\n   OR any(s IN coalesce(gi.synonyms, []) WHERE toLower(s) = toLower('TOP1'))\nOPTIONAL MATCH (t)-[:TARGETS]->(gx:Gene)\nWHERE toLower(gx.symbol) = toLower('KDR')\n   OR any(s IN coalesce(gx.synonyms, []) WHERE toLower(s) = toLower('KDR'))\nWITH t, gi, gx\nWHERE gx IS NULL\nMATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'ureter' AND\n    toLower(rel.disease_name) CONTAINS 'small' AND\n    toLower(rel.disease_name) CONTAINS 'cell' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nRETURN\n  CASE WHEN b:Variant THEN b.name ELSE NULL END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "generated_cypher": "MATCH (g:Gene {symbol: 'TOP1'})-[:VARIANT_OF]->(v:Variant)\nWITH v, g\nMATCH (g)-[:TARGETS]->(t:Therapy)\nWHERE NOT EXISTS {\n    (g)-[:TARGETS]->(t2:Therapy)\n    WHERE t2.symbol = 'KDR'\n}\nWITH t, g\nMATCH (d:Disease {name: 'Ureter Small Cell Carcinoma'})\nWHERE toLower(d.name) CONTAINS toLower('ureter small cell carcinoma')\nRETURN t.name AS therapy_name\nORDER BY therapy_name\nLIMIT 10", "gold_rows": [{"variant_name": "RAD50 L1237F", "gene_symbol": "RAD50", "therapy_name": "Irinotecan", "effect": "sensitivity", "disease_name": "Ureter Small Cell Carcinoma", "pmids": ["24934408"]}], "generated_rows": [], "error": null}
{"id": "F1.2-000189", "question": "Which genes does Tarloxotinib target?", "gold_cypher": "MATCH (t:Therapy)-[r:TARGETS]->(g:Gene)\nWHERE (\n  toLower(t.name) = toLower('Tarloxotinib')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Tarloxotinib'))\n  OR toLower(t.name) CONTAINS toLower('Tarloxotinib')\n)\nRETURN\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 100\n", "generated_cypher": "MATCH (g:Gene), (t:Therapy)\nWHERE t.name = 'Tarloxotinib'\nRETURN g.symbol AS gene_symbol\nORDER BY gene_symbol\nLIMIT 10", "gold_rows": [{"gene_symbol": "EGFR", "therapy_name": "Tarloxotinib", "targets_moa": "Epidermal growth factor receptor inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["33355298"], "ref_urls": ["https://pubmed.ncbi.nlm.nih.gov/33355298/"]}, {"gene_symbol": "ERBB2", "therapy_name": "Tarloxotinib", "targets_moa": "Epidermal growth factor receptor inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["33355298"], "ref_urls": ["https://pubmed.ncbi.nlm.nih.gov/33355298/"]}, {"gene_symbol": "ERBB3", "therapy_name": "Tarloxotinib", "targets_moa": "Epidermal growth factor receptor inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["33355298"], "ref_urls": ["https://pubmed.ncbi.nlm.nih.gov/33355298/"]}, {"gene_symbol": "ERBB4", "therapy_name": "Tarloxotinib", "targets_moa": "Epidermal growth factor receptor inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["33355298"], "ref_urls": ["https://pubmed.ncbi.nlm.nih.gov/33355298/"]}], "generated_rows": [{"gene_symbol": "ABCB1"}, {"gene_symbol": "ABCC10"}, {"gene_symbol": "ABCC3"}, {"gene_symbol": "ABCG2"}, {"gene_symbol": "ABL1"}, {"gene_symbol": "ABL2"}, {"gene_symbol": "ACTA1"}, {"gene_symbol": "ACTB"}, {"gene_symbol": "ACTL6A"}, {"gene_symbol": "ACVR1"}], "error": null}
{"id": "F6.2-000127", "question": "What therapies target TOP1 but NOT PSMD6, and have biomarker evidence in Ureter Small Cell Carcinoma?", "gold_cypher": "MATCH (t:Therapy)-[:TARGETS]->(gi:Gene)\nWHERE toLower(gi.symbol) = toLower('TOP1')\n   OR any(s IN coalesce(gi.synonyms, []) WHERE toLower(s) = toLower('TOP1'))\nOPTIONAL MATCH (t)-[:TARGETS]->(gx:Gene)\nWHERE toLower(gx.symbol) = toLower('PSMD6')\n   OR any(s IN coalesce(gx.synonyms, []) WHERE toLower(s) = toLower('PSMD6'))\nWITH t, gi, gx\nWHERE gx IS NULL\nMATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'ureter' AND\n    toLower(rel.disease_name) CONTAINS 'small' AND\n    toLower(rel.disease_name) CONTAINS 'cell' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nRETURN\n  CASE WHEN b:Variant THEN b.name ELSE NULL END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "generated_cypher": "MATCH (g:Gene {symbol: 'TOP1'})-[:VARIANT_OF]->(v:Variant)\nWHERE v.name CONTAINS 'TOP1'\nWITH g, v\nMATCH (g)-[:TARGETS]->(t:Therapy)\nWHERE NOT EXISTS {\n    (g)-[:TARGETS]->(t2:Therapy)\n    WHERE t2.symbol = 'PSMD6'\n}\nWITH t\nMATCH (b:Biomarker)-[:AFFECTS_RESPONSE_TO]->(t)\nWHERE toLower(b.disease_name) CONTAINS 'ureter small cell carcinoma'\nRETURN t.name AS therapy_name, b.name AS biomarker_name\nLIMIT 10", "gold_rows": [{"variant_name": "RAD50 L1237F", "gene_symbol": "RAD50", "therapy_name": "Irinotecan", "effect": "sensitivity", "disease_name": "Ureter Small Cell Carcinoma", "pmids": ["24934408"]}], "generated_rows": [], "error": null}
